Filter by

Health Subcommittee

Sorted by Most Recent Airing

Showing 1 - 20 of 46 Show 46
  • [alt text]

    Labeling Genetically Modified Foods

    Industry and legal experts testified at a hearing on the role genetic engineering plays in the U.S. food supply and the impact of state-specific labeling regulations on interstate commerce…

    179 views
  • [alt text]

    Health Care for September 11 Victims

    National Institute for Occupational Safety and Health Director John Howard testified at a hearing on the bill to reauthorize the World Trade Center Health Program and the September 11th…

    152 views
  • [alt text]

    Restaurant and Fast Food Nutrition Labeling

    Witnesses testified about menu labeling guidelines set forth by the Food and Drug Administration (FDA) as mandated in the Affordable Care Act. The guidelines require restaurants and…

    212 views
  • [alt text]

    Health and Human Services Fiscal Year 2016 Budget

    Health and Human Services Secretary Sylvia Burwell testified before a House Energy and Commerce subcommittee on her department’s fiscal year 2016 budget request. Topics included…

    594 views
  • [alt text]

    Genetically Modified Food

    Food and Drug Administration (FDA) official Michael Landa testified at a hearing on the regulation of genetically modified food ingredients. In the second panel, advocates and…

    552 views
  • [alt text]

    Antibiotic Resistance and Drug Development

    Dr. Janet Woodcock testified at a House Energy and Commerce subcommittee hearing on combating antibiotic resistance and improving drug development. She outlined her concerns in…

    436 views
  • [alt text]

    Prescription Drugs and Medical Advances

    Secretary Sylvia Burwell and other government and private sector healthcare leaders testified about ongoing medical community efforts to improve and develop and new treatments and…

    359 views
  • [alt text]

    Health Care Law and Federal Subsidies

    Witnesses testified on federal subsidies to insurance providers under the Affordable Care Act. The subsidies, also referred to as “risk corridors,” limit health care…

    578 views
  • [alt text]

    Drug Development and Approval

    The House Energy and Commerce Subcommittee on Health held a hearing on ways to expedite the Food and Drug Administration’s (FDA) drug development and approval…

    266 views
  • [alt text]

    Generic Drug Labeling

    Witnesses testified at a hearing on the Food and Drug Administration’s FDA’s proposal to have generic drug makers update their safety labels as soon as the information becomes…

    234 views
  • [alt text]

    Medicare Fraud Protection

    Officials from the Health and Human Services Department and the Government Accountability Office testified at a hearing on ways to better manage the Medicare system and prevent instances of…

    785 views
  • [alt text]

    Drug Shortages

    Officials from the Food and Drug Administration and the Government Accountability Office testified on the findings of an report on the FDA’s efforts to address drug…

    542 views
  • [alt text]

    Physician Reimbursement Rates for Federal Health Programs

    Members heard from expert witnesses about legislative efforts to fix the sustainable growth rate (SGR), a formula used to determine Medicare payments to doctors.

    426 views
  • [alt text]

    HealthCare.gov Web Site Implementation

    Health and Human Services Kathleen Sebelius testified on the implementation of the Healthcare.gov Web site. In her opening statement she said in she had launched an internal review of…

    1,829 views
  • [alt text]

    Affordable Care Act and Medicare Advantage

    Witnesses testified on the impact of the Affordable Care Act on the Medicare Advantage program. Medicare Advantage plans are the private health coverage that older people can get as an…

    1,277 views
  • [alt text]

    FDA Safety and Innovation Act, Part 2

    Senior Food and Drug Administration (FDA) officials gave an update on the implementation of the 2012 FDA Safety and Innovation Act. They told committee members that the overall process…

    229 views
  • [alt text]

    FDA Safety and Innovation Act, Part 1

    Senior Food and Drug Administration (FDA) officials gave an update on the implementation of the 2012 FDA Safety and Innovation Act. They told committee members that the overall process…

    326 views
  • [alt text]

    Medicaid System

    Witnesses testified about implementation of the Affordable Care Act and on proposals to reform the Medicaid program. They focused on expansion of Medicaid by states, costs of…

    207 views
  • [alt text]

    Prescription Drug Abuse

    Officials testified about prescription drug abuse and prevention programs. Among the topics they addressed were increased prescription abuse rates over the past several years, the…

    200 views
  • [alt text]

    Health Insurance and Pre-Existing Conditions

    Witnesses testified on state-level efforts to deal with a component of the health care law, high-risk health insurance pools designed to protect people with pre-existing medical…

    353 views
  • Load 20 More